JAK Inhibitor a Hit With RA Patients

(MedPage Today) -- Patients with rheumatoid arthritis (RA) treated with upadacitinib (Rinvoq) reported outcomes that were similar or superior to those seen with adalimumab (Humira), a post-hoc analysis of randomized clinical trial data found....